跳至主要内容
临床试验/CTRI/2018/05/013981
CTRI/2018/05/013981已完成1 期

MRSA Dermal Decolonization Study - MDDS

BioPlx Microbiomics Pvt Ltd0 个研究点目标入组 765 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
765

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Microbiological test results showing MRSA colonization, such as positive CHROMagar• MRSA plate reading

排除标准

  • 2. autoimmune disease
  • 3. congenital immunodeficiencies
  • 4. uncontrolled diabetes mellitus
  • 5. breast-feeding women or women who were or might become pregnant during the study period
  • 6. known history of HIV infection
  • 7. concurrent and chronic therapy with immunosuppressive drugs
  • 8. receipt of a live-virus vaccine during the last 2 months
  • 9. recent use of corticosteroids or other immunosuppressive medications
  • 10. eczema
  • 11. psoriasis
  • 12. atopic dermatitis
  • 13. seborrheic dermatitis
  • 14. drug eruptions
  • 15. rosacea, hives (urticaria) > dry skin (xerosis)
  • 16. administration/consumption of topical or systemic antibiotics in the last 14 days
  • 17. active psychiatric disease
  • 18. history of major depression, psychosis, or in-patient hospitalization for psychiatric management.

研究者

发起方
BioPlx Microbiomics Pvt Ltd

相似试验